Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes

American Journal of Reproductive Immunology

Volumn 51, Issue 1, 2004, Pages 22-31

  Janis, Kelly ^a   Hoeltke, Janice ^a   Nazareth, Michael ^a   Fanti, Peter ^a   Poppenberg, Kristin ^a   Aronica, Susan M ^a  

^a CANISIUS COLLEGE   (United States)

Author keywords

Chemokine; Chemokine receptor; Estrogen; Monocyte

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; ESTRADIOL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL ISOLATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS; DOWN-REGULATION; ESTROGENS; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C3H; MONOCYTES; RECEPTORS, CHEMOKINE;

EID: 0442325394     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.8755-8920.2003.00117.x     Document Type: Article

References (42)

1. Jacobs HS: Hormone replacement therapy and breast cancer. Endocrine-Related Cancer 2000; 7:53-61.
2. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332:1589-1593.
3. Colditz GA: Relationships between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998; 90:814-823.
4. Pritchard KI: Current and future directions in medical therapy for breast carcinoma: Endocrine treatment. Cancer 2000; 88:3065-3072.
5. Grainger DJ, Metcalfe JC: Tamoxifen: Teaching an old drug new tricks. Nat Med 1996; 2:381-385.
6. Novotny L, Rauko P, Vachalkova A, Peterson-Biggs M: Tamoxifen in cancer therapy. Neoplasma 2000; 47:3-7.
7. Jordan VC, Morrow M: Tamoxifen, raloxifene and the prevention of breast cancer. Endocr Rev 1999; 20:253-278.
8. Inadera H, Sekiya T, Yoshimura T, Matsushima K: Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology 2000; 141:50-59.
9. Okada M, Suzuki A, Mizuno K, Asada Y, Ino Y, Kuwayama T, Tamakoshi K, Mizutani S, Tomoda Y: Effects of 17b-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro. Cardiovasc Res 1997; 34:529-535.
10. Kovacs EJ, Faunce DE, Ramer-Quinn DS, Mott FJ, Dy PW, Frazier-Jessen MR: Estrogen regulation of JE/MCP-1 mRNA expression in fibroblasts. J Leukoc Biol 1996; 59:562-568.
11. Miller L, Hunt LS: Sex steroid hormones and macrophage function. Life Sci 1996; 59:1-14.
12. Berstein LM, Santen RJ, Santner SJ: Three-component model of oestrogen formation and regulation of intramural oestrogen pool in breast neoplasms. Med Hypotheses 1995; 45:588-590.
13. Jansson L, Holmdahl R: Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998; 47:290-301.
14. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT: Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-226.
15. Paavonen T: Hormonal regulation of immune responses. Ann Med 1994; 26:255-258.
16. Franzier-Jessen MR, Kovacs EJ: Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995; 154:1838-1845.
17. Gale LM, McColl SR: Chemokines: Extracellular messengers for all occasions. Bioessays 1999; 21:17-28.
18. Horuk R, Ng HP: Chemokine receptor antagonists. Med Res Rev 2000; 20:155-168.
19. Melchers F, Rolink AG, Schaniel C: The role of chemokines in regulating cell migration during humoral immune responses. Cell 1999; 99:351-354.
20. Yamada K, Hayashi T, Kuzuya M, Naito M, Asai K, Iguchi A: Physiological concentration of 17 beta-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein 1. Artery 1996; 22:24-35.
21. Saji H, Koike M, Yamori T, Saji S, Seike M, Matsushima K, Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast cancer. Cancer 2001; 92:1085-1091.
22. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P: Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 1999; 103:1269-1276.
23. Frade JM, Mellado M, Del Real G, Gutierrez-Ramos JC, Lind P, Martinez AC: Characterization of the CCR2 chemokine receptor: Functional CCR2 receptor expression in B cells. J Immunol 1997; 159:5576-5584.
24. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN: Expression of the interferon-g-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2000; 26:133-142.
25. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA: Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 1998; 273:18,288-18,291.
26. Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, Jensen B, Madsen HO, Ryder LP, Sveigaard A, Malling HJ, Skov PS, Poulsen LK: CXC chemokine receptor 3 expression on CD34+ hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: Chemotaxis and adhesion induced by its ligands, interferon γ-inducible protein 10 and monokine induced by interferon γ. Blood 2000; 96:1230-1238.
27. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5:919-923.
28. Porcu P, Gaddy J, Broxmeyer HE: Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Natl Acad Sci USA 1998; 95:4538-4543.
29. Stewart CC, Stewart SJ: Cell preparation for the identification of leukocytes. In Methods of Cell Biology, Vol. 64, Chapter 11, Z Danzynkiewicz, H Crissman, JP Robinson (eds). New York, Academic Press Inc., 2001, p. 218.
30. Kim C, Broxmeyer HE: In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998; 91:100-110.
31. Devor DC, Sekar MC, Frizzell RA, Duffey ME: Taurodeoxycholate activates potassium and chloride conductances via an IP3-mediated release of calcium from intracellular stores in a colonic cell line (T84). J Clin Invest 1993; 92:2173-2181.
32. Han KH, Han KO, Green SR, Quehenberger O: Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: Differentiated effects of plasma lipoproteins on monocyte function. J Lipid Res 1999; 40:1053-1063.
33. Wakeling AE: Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocrine-Related Cancer 2000; 7:17-28.
34. Katzenellenbogen BS: Antiestrogen resistance: Mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 1991; 83:1434-1435.
35. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G: Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo possible mechanisms for gender differences in atherosclerosis. Circ Res 1999; 85:377-385.
36. 2+ increase in human adherent monocytes. Blood 1995; 86:2388-2394.
37. Vaddi K, Newton RC: Comparison of biological responses of human monocytes and THP-1 cells of chemokines of the intercrine-beta family. J Leukoc Biol 1994; 55:756-762.
38. Sozzani S, Molino M, Locati M, Luini W, Cerletti C, Vecchi A, Mantovani A: Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J Immunol 1993; 150:1544-1553.
39. Fantuzzi L, Borghi P, Ciolli V, Pavlakis G, Belardelli F, Gessani S: Loss of CCR2 expression and functional response to chemotactic protein (MCP-1) during the differentiation of human monocytes: Role of secreted MCP-1 in the regulation of the chemotactic response. Blood 1999; 94:875-883.
40. Yen H, Zhang Y, Penfold S, Rollins BJ: MCP-1 mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol 1997; 61:529-532.
41. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-1814.
42. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997; 61:246-257.